vTv Therapeutics Inc sell tamam
Start price
18.04.18
/
50%
€2.07
Target price
31.05.18
€1.08
Performance (%)
-7.83%
End price
31.05.18
€1.91
Summary
This prediction ended on 31.05.18 with a price of €1.91. With a performance of -7.83%, the SELL prediction by tamam was trending in the right direction. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| vTv Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -2.116% | -8.178% | -1.471% | 54.145% |
| iShares Nasdaq 100 | -1.132% | 0.908% | 19.961% | 83.323% |
| iShares Nikkei 225® | -0.658% | -6.257% | 27.473% | 53.605% |
| iShares S&P 500 | -1.261% | -1.001% | 13.631% | 62.624% |
Comments by tamam for this prediction
In the thread vTv Therapeutics Inc diskutieren
vTv Therapeutics' azeliragon flunks late-stage Alzheimer's study
Bottom feeders have stampeded into fallen biotech vTv Therapeutics
(Vom Mitglied beendet)